IP Library Granted Patent US 11,260,155
Granted Patent B2
US 11,260,155 · App. 16/659,941 · Granted Mar 1, 2022

Dual reservoir hemodialysis system

Inventors: Osman Khawar (Irvine, CA); Clayton Poppe (Irvine, CA)
Assignee: DIALITY INC.
A61M1/1696A61M1/1601A61M1/1603A61M1/1625A61M1/1633A61M1/1694A61M1/267A61M1/3661A61M2202/0498A61M2205/3334A61M2205/3337
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,260,155
App. No.
16/659,941
Granted
Mar 1, 2022
Kind
B2
Abstract

A portable hemodialysis system is provided including a dialyzer, a closed loop blood flow path which transports blood from a patient to the dialyzer and back to the patient, and a closed loop dialysate flow path which transports dialysate through the dialyzer. In addition, the hemodialysis system includes two reservoirs which can be alternately placed in the dialysis flow path using various controllable fluid valves. The hemodialysis system may include a sorbent filter in the dialysate flow path which filters used dialysate. Alternatively, the filter may be positioned within a separate closed loop filter flow path which is isolated from the blood flow path and dialysate flow path. For this embodiment, the hemodialysis system includes additional controllable fluid valves which selectively connect the filter flow path to the reservoir which is not currently providing dialysis treatment to a patient.

Claims (28)

1. A hemodialysis system comprising:

an arterial blood line for connecting to a patient's artery for collecting blood from a patient;

a venous blood line for connecting to a patient's vein for returning blood to a patient;

a dialyzer;

a closed loop blood flow path which connects to said arterial blood line and said venous blood line for transporting blood from a patient to said dialyzer and back to a patient;

a blood pump for pumping blood through said blood flow path;

a first reservoir for storing a dialysate solution, said first reservoir having an inlet and an outlet;

a second reservoir for storing a dialysate solution, said second reservoir having an inlet and an outlet;

a closed loop dialysate flow path, isolated from the blood flow path, which transports a dialysate from said first reservoir or said second reservoir to said dialyzer and back to said first reservoir or second reservoir, said dialysate flow path including a first reservoir flow path connecting said first reservoir inlet and said first reservoir outlet to said dialysate flow path, and said dialysate flow path including a second reservoir flow path connecting said second reservoir inlet and said second reservoir outlet to said dialysate flow path,

at least one dialysate pump for pumping dialysate through said dialysate flow path;

a first reservoir fluid valve assembly which opens to permit the flow of dialysate through said first reservoir flow path or closes to obstruct the flow of dialysate through said first reservoir flow path;

a second reservoir fluid valve assembly which opens to permit the flow of dialysate through said second reservoir flow path or closes to obstruct the flow of dialysate through said second reservoir flow path; and

a processor connected to said first reservoir fluid valve assembly and said second first reservoir fluid valve assembly, said processor programmed to selectively alternate between,

1) the opening of said first fluid valve assembly to permit the flow of dialysate through said first reservoir flow path while closing said second fluid valve assembly to obstruct the flow of dialysate through said second reservoir flow path, and

2) the closing of said first fluid valve assembly to obstruct the flow of dialysate through said first reservoir flow path while opening said second fluid valve assembly to permit the flow of dialysate through said second reservoir flow path.

2. The hemodialysis system of claim 1 further comprising:

a filter which removes uremic toxins from water;

a closed loop filter flow path isolated from said blood flow path and said dialysate flow path, said filter flow path being a conduit for transporting a dialysate from said first reservoir or said second reservoir to said filter and back to the same first reservoir or second reservoir.

3. The hemodialysis system of claim 2 further comprising a pump and a source of reagents, both connected to said filter flow path.

4. The hemodialysis system of claim 1 further comprising:

a supply of fresh dialysate connected to both said first reservoir and said second reservoir;

fresh dialysate flow path connected to said supply of fresh dialysate, and said first reservoir and said second reservoir; and

a drain flow path connected to both said first reservoir and said second reservoir;

said processor connected to said supply of fresh dialysate and said drain flow path, said processor is programmed to drain the dialysate through said drain flow path and supply fresh dialysate to said first reservoir through said fresh dialysate flow path in the event that said first fluid valve assembly is obstructing the flow of dialysate through said first reservoir flow path, and said processor is programmed to drain the dialysate through said drain flow path and supply fresh dialysate through said fresh dialysate flow path to said second reservoir in the event that said second fluid valve assembly is obstructing the flow of dialysate through said second reservoir flow path.

5. The hemodialysis system of claim 1 further comprising:

a filter;

a bypass flow path; and

a bypass valve connected to said processor, said bypass valve diverting fluid in the dialysate flow path through said filter and not through said bypass flow path, or said bypass valve diverting fluid through said filter bypass flow path and not through said filter.

Assignments (3)
SECURITY INTEREST Recorded Jun 30, 2021
From: EXELA HOLDINGS, INC.; EXELA PHARMA SCIENCES, LLC; EXELA PHARMSCI, INC.; EXELA STERILE MEDICINES LLC; EXELA STERILE PRODUCTS LLC; EXELA STERILE EQUIPMENT, LLC; EXELA ADVANCED STRATEGIES LLC; AGELEX, LLC; EXELA HEALTH SYSTEMS, LLC; EXELA INITIATIVES, LLC; EXELA INNOVATIONS, LLC
To: LIVE OAK BANKING COMPANY
Reel/Frame 056722/0188 →
SECURITY INTEREST Recorded Jun 30, 2021
From: EXELA HOLDINGS, INC.; EXELA PHARMA SCIENCES, LLC; EXELA PHARMSCI, INC.; EXELA STERILE MEDICINES LLC; EXELA STERILE PRODUCTS LLC; EXELA STERILE EQUIPMENT, LLC; EXELA ADVANCED STRATEGIES LLC; AGELEX, LLC; EXELA HEALTH SYSTEMS, LLC; EXELA INITIATIVES, LLC; EXELA INNOVATIONS, LLC
To: LIVE OAK BANKING COMPANY
Reel/Frame 056722/0250 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: KHAWAR, OSMAN; POPPE, CLAYTON
To: DIALITY INC.
Reel/Frame 050842/0729 →
Continuity (2)
Provisional Application 62750647 · Oct 25, 2018
Related Publication 20200129686A1 · Apr 30, 2020